Description
Overview
Amylin receptor agonist is a polypeptide composed of 37 amino acids. Amylin is a hormone co-secreted by pancreatic beta cells and insulin, and is involved in the regulation of postprandial satiety. It is currently in clinical development as a single drug.
| Chemical Class | Amylin receptor agonist |
| Dosage Form | injection pen |
| Specification | Clinical exploration stage |
| Storage | Refrigerate at 2-8°C |
Mechanism of Action
- Amylin receptor activation: Acts on brainstem satiety center
- Delayed gastric emptying: reduces postprandial blood sugar fluctuations
- Synergizes with insulin: Mimics natural postprandial hormone balance
- Related to indications: As a complementary pathway to GLP-1, it can be used alone or in combination to enhance weight loss.
| Indication | Mechanism | Evidence |
|---|---|---|
| Weight management support | Amylin satiety signals | clinical exploration |
| Postprandial blood sugar management | Delayed gastric emptying | clinical exploration |
Dosage & Administration
- Data source: Based on ClinicalTrials.gov public trial protocol/approved instructions
Safety Information
- Data source: Based on PubMed safety research literature
Regulatory Status
Drug Interactions
- Data source: Derivation based on mechanism of action + PubMed literature
FAQ
Disclaimer: This product is intended for research purposes only. Not for human consumption or therapeutic use. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.


Reviews
There are no reviews yet.